Presentation TCT 2024 Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials Presenter: Didier Tchetche October 29, 2024
Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten Vahl October 29, 2024
Presentation TCT 2024 TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope Presenter: Ricky E Lemus-Zamora October 29, 2024
Presentation TCT 2024 TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation Presenter: Norman Mangner October 29, 2024
Presentation TCT 2024 TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk Presenter: José Antonio Baz Alonso October 29, 2024
Presentation TCT 2024 TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR) Presenter: Bruce Adrian Casipit October 29, 2024
Presentation TCT 2024 TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation Presenter: Sindhuja Palle October 29, 2024
Presentation TCT 2024 TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial Presenter: Pieter Smits October 29, 2024
Presentation TCT 2024 TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement Presenter: Usman Akbar October 29, 2024
Presentation TCT 2024 TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy Presenter: Eric Rytkin October 29, 2024
Presentation TCT 2024 Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial Presenter: Tobias Rheude October 29, 2024
Presentation TCT 2024 Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial Presenter: Thomas Pilgrim October 29, 2024
Presentation TCT 2024 Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial Presenter: Samir Kapadia October 29, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
Presentation TCT 2024 Case: Rising Gradients Soon After TAVR Presenter: Mahesh Madhavan October 28, 2024
Presentation TCT 2024 Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve Presenter: Ron Waksman October 28, 2024
Presentation TCT 2024 Comparative Data of Valve Performance Between Latest Generation Intra-Annular Versus Supra-Annular Self-Expandable Transcatheter Heart Valves in Small Aortic Annuli Presenter: Masahiko Asami October 28, 2024
News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
Presentation TCT 2024 Post-TAVR Risk-Stratification for Conduction Disturbances Presenter: Shmuel Chen October 28, 2024
Presentation TCT 2024 Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR Presenter: Amit Vora October 28, 2024